Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Excellence in Healthcare Investments

Why invest in healthcare? 

A megatrend and powerful innovation in one

  • The world’s population is increasing and aging at the same time. Lifestyle diseases are on the rise worldwide. Households in emerging markets have become richer. Demand for healthcare products and services is increasing around the world in the wake of these developments.
  • The global growth of the healthcare industry has outpaced world GDP growth during the past decade.
  • Healthcare expenditure does not fluctuate much because there is little correlation between the underlying demand for healthcare and the economic cycle.
  • The innovative power in life sciences, driven by tremendous research and development efforts, makes this investment universe all the more attractive
  • 10.8%

    of global GDP goes to healthcare, 
    led by the US at 17.3% of GDP 
     

  • USD 186 bn

    global spending on 
    pharmaceutical R&D in 2020
     

  • 55

    new drug approvals by the U.S. Food and Drug Administration (FDA) in 2023, the second highest number ever 

What does this mean for investors?

The global megatrend of healthcare offers investors better-than-average long-term growth potential with an ideal risk/reward profile. Given the depth and breadth of the healthcare market, ranging from medicines and medical technology to healthcare services and other segments, it presents a more diverse range of investment opportunities than other sectors, on top of the attractive return potential. Because this market is so complex, an active fundamental-based investment approach is recommended, which makes a variety of promising and innovative investment strategies possible. The complexity and the dynamics of the healthcare market not only speak in favor of active investment management strategies, they also call for specific expertise in every area of the healthcare sector. 

Why Bellevue?

We are proven experts in managing active, fundamental research-based healthcare investment vehicles. We boast a long and successful track record and have years of experience across several market cycles.

  • 1993

    European pioneer in the field of healthcare investing, having established the investment company BB Biotech in 1993 

  • 23

    Healthcare investment professionals 
    manage CHF 5.2 billion in assets 
    (as at Dec. 31, 2024) 
     

  • >10

    Our range of products is well 
    diversified in terms of sectors 
    and regions 
     

We have the necessary knowledge and expertise to successfully navigate the healthcare investment universe.

Our investment solutions

The investment products we offer reflect the breadth and depth of the healthcare market and our expertise and they address the differing needs of our clients.